Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma
Abstract Diffuse midline gliomas (DMGs) are aggressive pediatric brain tumors with dismal prognosis due to therapy-resistant tumor growth and invasion. We performed the first integrated histologic/genomic/proteomic analysis of 21 foci from three pontine DMG cases with supratentorial dissemination. H...
Main Authors: | M.-M. Georgescu, M. Z. Islam, Y. Li, M. L. Circu, J. Traylor, C. M. Notarianni, C. N. Kline, D. K. Burns |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40478-020-00992-9 |
Similar Items
-
Total copy number variation as a prognostic factor in adult astrocytoma subtypes
by: Kanish Mirchia, et al.
Published: (2019-06-01) -
Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis
by: Zeng C, et al.
Published: (2021-04-01) -
Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma
by: Sebastian Stasik, et al.
Published: (2020-12-01) -
Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients
by: Hainan Li, et al.
Published: (2021-03-01) -
Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma
by: Gabrielle Price, et al.
Published: (2021-07-01)